Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pediatr ; 119(2): 237-41, 1991 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1861208

RESUMEN

Analysis of data from the Kanto-Ko-Shin-Etsu Branch of the Japan Children's Cancer Registry revealed that mass screening for neuroblastoma increased the detection of cases in infants younger than 1 year from about 25% before screening to about 50%, and the percentage of neuroblastomas among all pediatric cancers almost doubled, from approximately 10% to 19.3%. However, when the cases found on screening were subtracted, the numbers after the onset of mass screening were similar to those before screening. It is likely that neuroblastoma mass screening has identified a unique type of tumor, which may not be recognized without mass screening, rather than that it has contributed to the earlier diagnosis of tumors in older children.


Asunto(s)
Tamizaje Masivo , Neuroblastoma/prevención & control , Factores de Edad , Cromatografía Líquida de Alta Presión , Ganglioneuroma/epidemiología , Ganglioneuroma/prevención & control , Ganglioneuroma/orina , Ácido Homovanílico/orina , Humanos , Lactante , Recién Nacido , Japón/epidemiología , Neuroblastoma/epidemiología , Neuroblastoma/orina , Prevalencia , Sistema de Registros , Ácido Vanilmandélico/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA